Federated Hermes, Inc. Maravai Lifesciences Holdings, Inc. Transaction History

Federated Hermes, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$4.7 - $9.87 $891,571 - $1.87 Million	-189,696 Reduced 80.89%	44,807 $293,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $12.85 $201,326 - $283,046	22,027 Added 10.37%	234,503 $2.35 Million
Q2 2023 Aug 14, 2023	SELL	$12.09 - $15.0 $158,959 - $197,220	-13,148 Reduced 5.83%	212,476 $2.64 Million
Q1 2023 May 08, 2023	SELL	$12.99 - $16.48 $237,223 - $300,957	-18,262 Reduced 7.49%	225,624 $3.16 Million
Q4 2022 Feb 13, 2023	BUY	$12.5 - $24.78 $2.33 Million - $4.62 Million	186,467 Added 324.75%	243,886 $3.49 Million
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $432,929 - $638,255	21,016 Added 57.73%	57,419 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $938,737 - $1.35 Million	36,036 Added 9819.07%	36,403 $1.03 Million
Q1 2022 May 13, 2022	SELL	$24.46 - $40.92 $571,385 - $955,891	-23,360 Reduced 98.45%	367 $13,000
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $2.23 Million - $2.92 Million	-63,614 Reduced 72.83%	23,727 $994,000
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $1.38 Million - $2.28 Million	37,599 Added 75.59%	87,341 $4.29 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $1.61 Million - $2.24 Million	49,742 New	49,742 $2.08 Million
Q1 2021 May 13, 2021	SELL	$25.8 - $38.49 $516,000 - $769,800	-20,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$24.5 - $30.86 $490,000 - $617,200	20,000 New	20,000 $561,000

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $687M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.